Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Tessa Therapeutics Announces Collaboration with Merck Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
2019-04-16 07:15
Tessa Therapeutics Announces Collaboration with MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and Virus-Specific T Cell Therapy Targeting Human Papillomavirus in Cervical Cancer
2019-04-16 07:15
BioAtla Subsidiary, Himalaya Therapeutics, Will Develop And Commercialize CAB Products In Greater China Market
2019-04-16 06:00
China Jo-Jo Drugstores Announces the Closing of $10 Million Registered Direct Offering
2019-04-16 04:00
Shanghai Pharma Unveils Stock Incentive Plans to Accelerate Global Ambition
2019-04-15 20:00
Ganovo is Eligible for the Basic Medical Insurance of Zhejiang Province - Reimbursement-by-disease
2019-04-15 17:12
#RosaceaNoFilter: Online Influencers Take the Lead in Raising Rosacea Awareness in Galderma's Empowering Rosacea Awareness Month Social Media Campaign
2019-04-15 16:04
CStone received IND approval in China for avapritinib Phase I/II bridging registrational study in patients with advanced gastrointestinal stromal tumors
2019-04-15 14:32
The next stage in wheelchair evolution -- Permobil's new F-Series to launch in Japan
2019-04-15 09:00
Medtec China - MDiT Forum and Regulation Summit 2019 will be held in Shanghai this fall
2019-04-15 09:00
Stryker launches next generation flow diverter for treatment of brain aneurysms
2019-04-15 04:00
Ortoma Signs Exclusivity Agreement
2019-04-12 15:32
Wuhan Lays Out Construction of Guanggu Nanda Health Industrial Park
2019-04-12 14:06
World First Development of an Arsenic-Peptide to Target Cancer
2019-04-12 14:00
Clinicians and phototherapy patients gain advantage with new ultraviolet UVB LEDs
2019-04-11 22:00
Anpac Bio CDA Liquid Biopsy Technology Selected by FAST COMPANY 2019 "WORLD CHANGING IDEAS AWARD"
2019-04-11 21:45
China Jo-Jo Drugstores Announces $10 Million Registered Direct Offering
2019-04-11 21:25
Ping An Good Doctor Launches "One-Minute Clinic" at Shanghai Jiao Tong University
2019-04-11 20:43
I-Mab Biopharma Signs Agreement for Clinical Research of TJD5 in Combination Therapy
2019-04-11 10:34
Mallinckrodt's INOmax™ (Nitric Oxide) Gas, for Inhalation, Approved in Australia for Pulmonary Hypertension in Adults in Conjunction with Cardiovascular Surgery
2019-04-11 05:00
1
908
909
910
911
912
1599